| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: Bazar Gregory Matthew, Director
Granted 11,286 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Blizard Jeffrey, Director
Granted 11,286 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Tyler James, Director
Granted 11,286 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Miller Ian D., Director
Granted 12,697 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Frank Morgan C., Director
Granted 11,286 Stock Option (right to buy) |
| 25 Sep 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On September 23, 2026, Sanuwave Health, Inc., a Nevada corporation (the “Company”), received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that, for th... |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 06 Aug 2026 | 10-Q |
| 31 Jul 2026 | SCHEDULE 13G/A |
| 30 Jul 2026 | SCHEDULE 13G/A |
| 13 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 02 Jul 2026 |
Form 4: Blizard Jeffrey, Director
Granted 5,524 Stock Option (right to buy) |
| 02 Jul 2026 |
Form 4: Miller Ian D., Director
Granted 6,215 Stock Option (right to buy) |
| 02 Jul 2026 |
Form 4: Bazar Gregory Matthew, Director
Granted 5,524 Stock Option (right to buy) |
| 02 Jul 2026 |
Form 4: Tyler James, Director
Granted 5,524 Stock Option (right to buy) |
| 02 Jul 2026 |
Form 4: Frank Morgan C., Director
Granted 5,524 Stock Option (right to buy) |
| 16 Jun 2026 | 8-K: Regulation FD Disclosure |
| 15 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 29 May 2026 | SD |
Loading...
